Barbara Metch

2.1k citations

32 papers · 1.1k indexed · h-index 18

Infectious Diseases top 5%
Public Health, Environmental and Occupational Health top 5%
Virology top 2%
Epidemiology top 10%
Molecular Biology

Co-authors: Gilbert S. Omenn Gary E. Goodman Susan Buchbinder Mark Thornquist Susan Scheer Eric Vittinghoff Anne Coletti Sarah Holte
Topics: HIV Research and Treatment (11 papers)HIV/AIDS Research and Interventions (11 papers)HIV, Drug Use, Sexual Risk (8 papers)
Cited by: Virology Biochemistry Infectious Diseases
Journals: New England Journal of Medicine PLoS ONE American Journal of Public Health
Partner nations: United States South Africa Puerto Rico

In The Last Decade

Barbara Metch

32 papers receiving 1.1k citations

Peers

Countries citing papers authored by Barbara Metch

Since Specialization

Citations

This map shows the geographic impact of Barbara Metch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Metch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Metch more than expected).

Fields of papers citing papers by Barbara Metch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Metch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Metch. The network helps show where Barbara Metch may publish in the future.

Co-authorship network of co-authors of Barbara Metch

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Metch. A scholar is included among the top collaborators of Barbara Metch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Metch. Barbara Metch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Substance use patterns of HVTN phase I clinical trial participants: Enrollment, risk reduction counseling and retention 2018 ·Vaccine ·(unknown),Barbara Metch,Cameron S. Sharpe,(unknown),Michele P. Andrasik	2
2	Selection of HIV vaccine candidates for concurrent testing in an efficacy trial 2016 ·Current Opinion in Virology ·Ying Huang,(unknown),Carlos A. DiazGranados,Holly Janes,(unknown),(unknown),Allan C. deCamp,Barbara Metch,Shannon Grant,Brittany Sanchez,Sanjay Phogat,Marguerite Koutsoukos,Niranjan Kanesa-thasan,Patricia Bourguignon,Alix Collard,Susan Buchbinder,Georgia D. Tomaras,M. Juliana McElrath,Glenda Gray,James G. Kublin,Lawrence Corey,Peter B. Gilbert	7
3	Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men 2015 ·PLoS ONE ·Zoe Moodie,Barbara Metch,Linda‐Gail Bekker,Gavin Churchyard,Maphoshane Nchabeleng,Koleka Mlisana,Fatima Laher,Surita Roux,Kathryn Mngadi,Craig Innes,Matsontso Mathebula,Mary Allen,Carter Bentley,Peter B. Gilbert,Michael Robertson,James G. Kublin,Lawrence Corey,Glenda Gray	25
4	Feasibility of Identifying a Female Sex Worker Cohort at High Risk of HIV Infection in the Caribbean for HIV Vaccine Efficacy Trials 2015 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Marie Deschamps,Barbara Metch,Cecilia Morgan,(unknown),Yeycy Donastorg,Edith Swann,(unknown),(unknown),W. John Pape	14
5	Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study 2014 ·The Lancet Infectious Diseases ·Glenda Gray,Zoe Moodie,Barbara Metch,Peter B. Gilbert,Linda‐Gail Bekker,Gavin Churchyard,Maphoshane Nchabeleng,Koleka Mlisana,Fatima Laher,Surita Roux,Kathryn Mngadi,Craig Innes,Matsontso Mathebula,Mary Allen,(unknown),Michael Robertson,James G. Kublin,Lawrence Corey	82
6	Recruitment of Caribbean female commercial sex workers at high risk of HIV infection. 2013 ·PubMed ·Marie Deschamps,Carmen Zorrilla,Cecilia Morgan,Yeycy Donastorg,Barbara Metch,Tamra Madenwald,(unknown),(unknown),(unknown),(unknown),(unknown),Edith Swann,Jean W. Pape,(unknown)	16
7	Feasibility of Identifying a Cohort of US Women at High Risk for HIV Infection for HIV Vaccine Efficacy Trials 2013 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Beryl A. Koblin,Barbara Metch,Richard Novák,Cecilia Morgan,Debbie Lucy,(unknown),(unknown),Edith Swann,Tamra Madenwald,(unknown),Ian Frank	12
8	Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition 2013 ·AIDS ·Richard Novák,Barbara Metch,Susan Buchbinder,Robinson Cabello,Yeycy Donastorg,(unknown),(unknown),(unknown),Ellen Koenig,David S. Metzger,(unknown),Mark Tyndall,(unknown)	11
9	Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa? 2013 ·Vaccine ·Glenda Gray,Barbara Metch,Gavin Churchyard,Koleka Mlisana,Maphoshane Nchabeleng,Mary Allen,Zoe Moodie,(unknown),Linda‐Gail Bekker	19
10	Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses 2012 ·Vaccine ·Stephen R. Walsh,Michael S. Seaman,Lauren E. Grandpre,(unknown),Katherine E. Yanosick,Barbara Metch,Michael C. Keefer,Raphael Dolin,Lindsey R. Baden	8
11	Recruitment of Urban US Women at Risk for HIV Infection and Willingness to Participate in Future HIV Vaccine Trials 2012 ·AIDS and Behavior ·Barbara Metch,Ian Frank,Richard M. Novak,Edith Swann,David S. Metzger,Cecilia Morgan,Debbie Lucy,(unknown),(unknown),Tamra Madenwald,(unknown),Beryl A. Koblin	11
12	Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected Adults 2012 ·PLoS ONE ·Spyros A. Kalams,Scott Parker,Xia Jin,Marnie Elizaga,Barbara Metch,Maggie Haitian Wang,John Hural,Michael D. Lubeck,John H. Eldridge,M. Cardinali,William A. Blattner,Magda Sobieszczyk,Vinai Suriyanon,Artur Olhovetchi Kalichman,David B. Weiner,Lindsey R. Baden,(unknown)	90
13	A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects☆☆☆ 2011 ·Vaccine ·Michael C. Keefer,Sharon E. Frey,Marnie Elizaga,Barbara Metch,Stephen C. De Rosa,Paulo Feijó Barroso,Georgia D. Tomaras,M. Cardinali,Paul A. Goepfert,Artur Olhovetchi Kalichman	38
14	The HVTN Protocol 903 Vaccine Preparedness Study 2008 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Gaston Djomand,Barbara Metch,Carmen Zorrilla,Yeycy Donastorg,Martín Casapía,Tonya Villafana,Jean W. Pape,Peter Figueroa,Marianne Nordli Hansen,Susan Buchbinder,Chris Beyrer	25
15	Lessons From a Multisite International Trial in the Caribbean and South America of an HIV-1 Canarypox Vaccine (ALVAC-HIV vCP1452) With or Without Boosting With MN rgp120 2007 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Farley Cleghorn,Jean W. Pape,Mauro Schechter,Courtenay Bartholomew,Jorge Sánchez,Noreen Jack,Barbara Metch,Marianne Hansen,Mary Allen,Huyen Cao,David C. Montefiori,Georgia D. Tomaras,Sanjay Gurunathan,Donna J. Eastman,Regina Ferro do Lago,(unknown),Javier R. Lama,Dale N. Lawrence,Peter F. Wright	25
16	Determinants of Enrollment in a Preventive HIV Vaccine Trial 2004 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Susan Buchbinder,Barbara Metch,Sarah Holte,Susan Scheer,Anne Coletti,Eric Vittinghoff	147
17	Demographic Factors That Influence the Neutralizing Antibody Response in Recipients of Recombinant HIV‐1 gp120 Vaccines 2004 ·The Journal of Infectious Diseases ·David C. Montefiori,Barbara Metch,M. Juliana McElrath,Steve Self,Kent J. Weinhold,Lawrence Corey,(unknown)	46
18	The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with asbestos-exposed workers. 1993 ·PubMed ·Gilbert S. Omenn,Gary E. Goodman,Mark Thornquist,Linda Rosenstock,Scott Barnhart,Ina Gylys-Colwell,Barbara Metch,(unknown)	44
19	Quality of life assessment in Southwest Oncology Group trials. 1990 ·PubMed ·Carol M. Moinpour,Katherine Hayden,Ian M. Thompson,Polly Feigl,Barbara Metch	44
20	Primary Tubal Infertility in Relation to the use of an Intrauterine Device 1985 ·Studies in Family Planning ·Janet R. Daling,Noel S. Weiss,Barbara Metch,Wong Ho Chow,Richard M. Soderstrom,Donald E. Moore,(unknown),Bruce V. Stadel	3

About Barbara Metch

Barbara Metch is a scholar working on Virology, Biochemistry and Infectious Diseases, having authored 32 papers that have together received 1.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (11 papers), HIV/AIDS Research and Interventions (11 papers) and HIV, Drug Use, Sexual Risk (8 papers). The work is most often cited by research in Virology (270 citations), Biochemistry (151 citations) and Infectious Diseases (318 citations). Barbara Metch has collaborated with scholars based in United States, South Africa and Puerto Rico. Frequent co-authors include Gilbert S. Omenn, Gary E. Goodman, Susan Buchbinder, Mark Thornquist, Susan Scheer, Eric Vittinghoff, Anne Coletti, Sarah Holte, Donald E. Moore and Wong Ho Chow. Their work appears in journals such as New England Journal of Medicine, PLoS ONE and American Journal of Public Health.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact